CROI Conference Review 2014

In this review:

GSK744 for preventing HIV transmission in macaques
Safety and efficacy of dapivirine
Tenofovir vs. tenofovir/ emtricitabine as PrEP
Partners subset study interim results
PrEP – use it or lose it
NEAT001/ANRS143 trial
Atazanavir/ritonavir, raltegravir or darunavir/ritonavir vs. tenofovir/ emtricitabine
More on GSK744
Attachment inhibitor prodrug in ART-experienced subjects
Sensitive screening for transmitted HIV drug resistance
Ongoing issues with abacavir
Statins increase CD4-cell counts
HIV epidemiology/transmission
Oral HPV and oropharyngeal cancer
Bacterial vaginosis
Meningococcal outbreak among MSM in New York

Please login below to download this issue (PDF)

Subscribe